N-Nitroso-N-ethylurea (ENU)

ENU was synthesized in the 1950s and became the reference compound for assessing chemical mutagen potency — it has been used extensively in mouse mutagenesis screens (ENU mutagenesis) to generate mutations for understanding gene function [1]. It forms in vitro by the nitrosation of ethylurea, and could potentially form in vivo when urea or ethyl-containing food components interact with nitrite in the stomach, though this environmental formation pathway is less studied than for simple nitrosamines [2]. ENU is not produced commercially except for research purposes; its extreme potency makes large-scale production unnecessary and dangerous [1].

Exposure is essentially limited to research laboratories where ENU is used intentionally for mutagenesis experiments [1]. Trace formation from environmental nitrosation reactions involving urea compounds is possible but not a documented significant exposure pathway [2]. The general public has no meaningful ENU exposure [1].

ENU ethylates DNA with extraordinary efficiency at multiple positions — O-6-ethylguanine, O-4-ethylthymine, and O-2-ethylthymine adducts are formed [1]. The O-6-ethylguanine adduct is particularly mutagenic, causing G→A transition mutations if not repaired before replication. At doses achievable in animal experiments, ENU induces tumors of the brain, spinal cord, kidney, and thyroid with extremely high efficiency [2]. IARC classifies it as Group 2A (probably carcinogenic to humans) [1].

Research laboratory workers who handle ENU for mutagenesis experiments [1]. No public exposure pathway [2].

1. All ENU handling must occur in a certified chemical fume hood with double gloves and impermeable lab coat [1]. 2. ENU must be deactivated before disposal — treatment with sodium hydroxide solution converts it to inactive ethanol and CO2 [2]. 3. Stringent documentation and institutional biosafety committee oversight required for all ENU use [1].